Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.

In 1991, about 500 000 Americans had a stroke (400 000 had an ischemic stroke) and more than 143 000 died.' More than 3 000 000 people in the United States have survived a stroke. In 1994 the annual economic costs of stroke due to health care expenses and lost productivity are estimated to be nearly $20 billion.' In spite of these human and financial costs, stroke unfortunately has not received a great deal of attention, and its management has been marred by an element of nihilism.2 Caplan3 concludes that past failures to establish effective therapies for stroke are due to problems in clinical trial design, lack of interest in care of stroke, and lack of available technologies to evaluate patients. However, with advances in diagnosis and treatment, stroke can now be managed as the life-threatening emergency that it is. In 1993 the American Heart Association included emergent stroke care as part of its special resuscitation situations for basic and advanced life support.4 This report builds on that statement. The goal of this special report is to provide information about the current management of acute ischemic stroke. It also provides recommendations for initial care (within 24 hours of stroke) based on currently available data from clinical trials. In the future, many therapies for stroke will be linked to very early (within 6 hours) intervention. No recommendations about rehabilitation or chronic medical or surgical measures to prevent recurrent stroke are made. To prepare this report, the members of the Stroke Council used the rules of evidence for specific treatments that have been used by other panels (Table 1).5 These rules give greater credence to the results of well-designed clinical trials than to anecdotal case reports or case series. The current recommendations will eventually be altered

[1]  U. Abildgaard,et al.  [Antithrombotic therapy in cerebrovascular disorders]. , 1995, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[2]  J. Talley,et al.  Heparin associated thrombocytopenia. , 1995, The Journal of the Arkansas Medical Society.

[3]  A. Gironell,et al.  Positional Cerebral Ischemia , 1995 .

[4]  J. Heit,et al.  Prevention of venous thromboembolism. , 1995, Chest.

[5]  H. Adams,et al.  Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. , 1994, Stroke.

[6]  L. Wilkins Stroke: A Clinical Approach, 2nd Ed. , 1993 .

[7]  P. Langhorne,et al.  Do stroke units save lives? , 1993, The Lancet.

[8]  J. Grotta,et al.  Should hypertension be treated after acute stroke? A randomized controlled trial using single photon emission computed tomography. , 1993, Archives of neurology.

[9]  W. Powers Acute hypertension after stroke , 1993, Neurology.

[10]  R. Higashida,et al.  Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries. , 1993, Journal of neurosurgery.

[11]  E. Massey,et al.  Aspiration in bilateral stroke patients , 1993, Neurology.

[12]  J. Bogousslavsky,et al.  Atrial Fibrillation After Acute Stroke , 1993, Stroke.

[13]  D. Krieger,et al.  Therapeutic Strategies in Space-Occupying Cerebellar Infarction Based on Clinical, Neuroradiological and Neurophysiological Data , 1993 .

[14]  T. Hayakawa,et al.  Intravenous Tissue Plasminogen Activator in Acute Thromboembolic Stroke: A Placebo-Controlled, Double-Blind Trial , 1993 .

[15]  Hall Ed The effects of glucocorticoid and nonglucocorticoid steroids on acute neuronal degeneration. , 1993 .

[16]  E. Hall The effects of glucocorticoid and nonglucocorticoid steroids on acute neuronal degeneration. , 1993, Advances in neurology.

[17]  M. Pessin,et al.  Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. , 1993, AJNR. American journal of neuroradiology.

[18]  M. Reding,et al.  Validation of the 3-oz water swallow test for aspiration following stroke. , 1992, Archives of neurology.

[19]  M. Gent,et al.  A Low-Molecular-Weight Heparinoid Compared with Unfractionated Heparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke , 1992, Annals of Internal Medicine.

[20]  L. Caplan What's wrong with Mr. Jones, a 58-year-old man with cerebrovascular disease? , 1992, Heart disease and stroke : a journal for primary care physicians.

[21]  J. Broderick,et al.  Relationship of Cardiac Disease to Stroke Occurrence, Recurrence, and Mortality , 1992, Stroke.

[22]  W. Hacke,et al.  Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke , 1992, Annals of neurology.

[23]  A. Yamadori,et al.  Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke , 1992, Neurology.

[24]  C. Hsu,et al.  Therapeutic potential for adenosine receptor activation in ischemic brain injury. , 1992, Journal of neurotrauma.

[25]  M. Kotila,et al.  Epilepsy After Stroke , 1992, Epilepsia.

[26]  W. Hacke,et al.  Safety and Efficacy of Intravenous Tissue Plasminogen Activator and Heparin in Acute Middle Cerebral Artery Stroke , 1992, Stroke.

[27]  J. Marler,et al.  Urgent Therapy for Stroke: Part II. Pilot Study of Tissue Plasminogen Activator Administered 91-180 Minutes From Onset , 1992, Stroke.

[28]  J. Broderick,et al.  Urgent Therapy for Stroke: Part I. Pilot Study of Tissue Plasminogen Activator Administered Within 90 Minutes , 1992, Stroke.

[29]  D. Pelz,et al.  The impact of magnetic resonance imaging on the management of acute ischemic stroke , 1992, Neurology.

[30]  A. Morabito,et al.  Venous thromboembolism in acute stroke. Prognostic importance of hypercoagulability. , 1992, Archives of neurology.

[31]  L. Bozzao,et al.  Acute cerebral ischemia: CT and MR findings. , 1992, AJNR. American journal of neuroradiology.

[32]  G. Donnan Investigation of patients with stroke and transient ischaemic attacks , 1992, The Lancet.

[33]  J. Bamford,et al.  Clinical examination in diagnosis and subclassification of stroke , 1992, The Lancet.

[34]  V. Hachinski,et al.  The cardiac consequences of stroke. , 1992, Neurologic clinics.

[35]  L. Wilkins Clinical Trial of Nimodipine in Acute Ischemic Stroke , 1992 .

[36]  G. Pasquale,et al.  Cardiac Arrhythmias Following Acute Brain Injuries , 1992 .

[37]  J. Ornato,et al.  Guidelines for cardiopulmonary resuscitation and emergency cardiac care, IV: Special resuscitation situations , 1992 .

[38]  W. H. Shuford Detection of cardiac chamber enlargement with the chest roentgenogram. , 1992, Heart disease and stroke : a journal for primary care physicians.

[39]  B. Fredholm,et al.  Adenosine and brain ischemia. , 1992, Cerebrovascular and brain metabolism reviews.

[40]  M D Ginsberg,et al.  Therapeutic modulation of brain temperature: relevance to ischemic brain injury. , 1992, Cerebrovascular and brain metabolism reviews.

[41]  B. Siesjö,et al.  Ischemic brain damage: focus on lipids and lipid mediators. , 1992, Advances in experimental medicine and biology.

[42]  J. Rothrock,et al.  Antithrombotic therapy in cerebrovascular disease. , 1991, Annals of internal medicine.

[43]  A. Algra,et al.  A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. , 1991, The New England journal of medicine.

[44]  R. Rothlein,et al.  Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion molecule. , 1991, Journal of neurosurgery.

[45]  J L Zito,et al.  Computed Tomographic‐Angiographic Findings Within the First Five Hours of Cerebral Infarction , 1991, Stroke.

[46]  J. Biller,et al.  Nihilism and stroke therapy. , 1991, Stroke.

[47]  D. Sackett,et al.  Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. , 1991, The New England journal of medicine.

[48]  M. Fisher,et al.  Immunohematologic characteristics of infection-associated cerebral infarction. , 1991, Stroke.

[49]  J. Grotta,et al.  Early treatment of ischemic stroke with a calcium antagonist. , 1991, Stroke.

[50]  S. Takahashi,et al.  Cerebral infarction: early detection by means of contrast-enhanced cerebral arteries at MR imaging. , 1991, Radiology.

[51]  L. Bozzao,et al.  Hyperdense middle cerebral artery CT sign. Comparison with angiography in the acute phase of ischemic supratentorial infarction. , 1991, Neuroradiology.

[52]  M. Hennerici,et al.  Effect of Nimodipine on Acute Ischemic Stroke Pooled Results From Five Randomized Trials , 1990, Stroke.

[53]  A. Slivka,et al.  Natural history of progressive ischemic stroke in a population treated with heparin. , 1990, Stroke.

[54]  T. N. t-P. S. S. Group Randomised, double-blind, placebo-controlled trial of nimodipine in acute stroke , 1990, The Lancet.

[55]  M. Moskowitz,et al.  Growth factor expression after stroke. , 1990, Stroke.

[56]  L. Goldstein Pharmacology of recovery after stroke. , 1990, Stroke.

[57]  J. Hallenbeck,et al.  Background review and current concepts of reperfusion injury. , 1990, Archives of neurology.

[58]  J Bamford,et al.  The frequency, causes and timing of death within 30 days of a first stroke: the Oxfordshire Community Stroke Project. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[59]  P. Zangger,et al.  Adjusted hypervolemic hemodilution in acute ischemic stroke. , 1990, Stroke.

[60]  J. Marler,et al.  High-dose intravenous naloxone for the treatment of acute ischemic stroke. , 1990, Stroke.

[61]  M. Hommel,et al.  Prospective study of lacunar infarction using magnetic resonance imaging. , 1990, Stroke.

[62]  S M Davis,et al.  Epileptic seizures in acute stroke. , 1990, Archives of neurology.

[63]  D. Choi,et al.  The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. , 1990, Annual review of neuroscience.

[64]  H. Adams,et al.  Use of antithrombotic drugs in the treatment of acute ischemic stroke , 1989, Neurology.

[65]  H. Adams,et al.  A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. , 1989, The New England journal of medicine.

[66]  G. Boysen,et al.  Hemodilution increases cerebral blood flow in acute ischemic stroke. , 1989, Stroke.

[67]  M. Fujishima,et al.  Hemorrhagic transformation in cerebral embolism. , 1989, Stroke.

[68]  G. Albers,et al.  N‐methyl‐D‐aspartate antagonists: Ready for clinical trial in brain ischemia? , 1989, Annals of neurology.

[69]  L. Wilkins Hypervolemic hemodilution treatment of acute stroke. Results of a randomized multicenter trial using pentastarch. The Hemodilution in Stroke Study Group. , 1989, Stroke.

[70]  D. W. Beck,et al.  A dose escalation study of ORG 10172 (low molecular weight heparinoid) in stroke , 1989, Neurology.

[71]  S. Levine Acute cerebral ischemia in a critical care unit. A review of diagnosis and management. , 1989, Archives of internal medicine.

[72]  M. Prins,et al.  Prophylaxis of deep venous thrombosis with a low-molecular-weight heparin (Kabi 2165/Fragmin) in stroke patients. , 1989, Haemostasis.

[73]  A. Norberg,et al.  Nutritional status in patients with acute stroke. , 2009, Acta medica Scandinavica.

[74]  F. Rubino,et al.  Postinfarction seizures. A clinical study. , 1988, Stroke.

[75]  E. Massey,et al.  Aspiration following stroke , 1988, Neurology.

[76]  J. Bogousslavsky,et al.  The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. , 1988, Stroke.

[77]  S. Jonas Anticoagulant therapy in cerebrovascular disease: review and meta-analysis. , 1988, Stroke.

[78]  Daniel B Hier,et al.  The Stroke Data Bank: design, methods, and baseline characteristics. , 1988, Stroke.

[79]  W. Crowe,et al.  Occult proximal deep vein thrombosis: its prevalence among patients admitted to a rehabilitation hospital. , 1988, Archives of physical medicine and rehabilitation.

[80]  G. Fabrizi HAEMODILUTION IN ACUTE STROKE: RESULTS OF THE ITALIAN HAEMODILUTION TRIAL , 1988, The Lancet.

[81]  D. Beevers,et al.  The frequency, characteristics and prognosis of epileptic seizures at the onset of stroke. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[82]  K. McPherson,et al.  Secondary prevention of vascular disease by prolonged antiplatelet treatment , 1988, British medical journal.

[83]  H. J. Gelmers,et al.  A controlled trial of nimodipine in acute ischemic stroke. , 1988, The New England journal of medicine.

[84]  R. Peto,et al.  Haemodilution in acute stroke: Results of the Italian haemodilution trial , 1988 .

[85]  V. Singh,et al.  Neurologic Basis of Voiding Disorders in Patients with Cerebrovascular Accident , 1988, Seminars in neurology.

[86]  J. Théron Angioplasty of Supra-Aortic Arteries , 1987 .

[87]  S. Black,et al.  The sensitivity and specificity of MRI in stroke , 1987, Neurology.

[88]  L. Wilkins Multicenter trial of hemodilution in acute ischemic stroke. I. Results in the total patient population. Scandinavian Stroke Study Group. , 1987 .

[89]  T. Olsen,et al.  Epilepsy after stroke , 1987, Neurology.

[90]  R. Ojemann,et al.  Emergency carotid endarterectomy. , 1987, Journal of neurosurgery.

[91]  J. Hirsh,et al.  DOUBLE-BLIND RANDOMISED TRIAL OF ORG 10172 LOW-MOLECULAR-WEIGHT HEPARINOID IN PREVENTION OF DEEP-VEIN THROMBOSIS IN THROMBOTIC STROKE , 1987, The Lancet.

[92]  R. Newcombe,et al.  DOUBLE-BLIND RANDOMISED TRIAL OF INTRAVENOUS GLYCEROL IN ACUTE STROKE , 1987, The Lancet.

[93]  K. Asplund,et al.  Multicenter trial of hemodilution in acute ischemic stroke. I. Results in the total patient population. Scandinavian Stroke Study Group. , 1987, Stroke.

[94]  K. Chhangani,et al.  Calcium antagonist. , 1987, The Journal of the Association of Physicians of India.

[95]  D. Sackett,et al.  Rules of evidence and clinical recommendations on the use of antithrombotic agents. , 1989, Chest.

[96]  A. Turpie,et al.  Intravenous heparin for the prevention of stroke progression in acute partial stable stroke. , 1986, Annals of internal medicine.

[97]  Monica Haputman Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest. , 1986, The New England journal of medicine.

[98]  M. Ramirez-Lassepas,et al.  Treatment of Acute Ischemic Stroke: Open Trial With Continuous Intravenous Heparinization , 1986 .

[99]  C. Hornig,et al.  Hemorrhagic cerebral infarction--a prospective study. , 1986, Stroke.

[100]  V. Hachinski,et al.  High dose steroid treatment in cerebral infarction. , 1986, British medical journal.

[101]  L. Caplan Stroke: A Clinical Approach , 1986 .

[102]  B. Siesjö Calcium and ischemic brain damage. , 1986, European neurology.

[103]  P. Black,et al.  External pneumatic calf compression reduces deep venous thrombosis in patients with ruptured intracranial aneurysms. , 1986, Neurosurgery.

[104]  G. Forbes,et al.  Emergency carotid endarterectomy for patients with acute carotid occlusion and profound neurological deficits. , 1986, Annals of surgery.

[105]  R. Hart,et al.  Hemorrhagic infarcts. , 1986, Stroke.

[106]  U. Degirolami,et al.  Tissue plasminogen activator reduces neurological damage after cerebral embolism. , 1985, Science.

[107]  H. Lüders,et al.  Epileptic Seizures Due to Thrombotic and Embolic Cerebrovascular Disease in Older Patients , 1985, Epilepsia.

[108]  J. Grotta,et al.  Baseline hemodynamic state and response to hemodilution in patients with acute cerebral ischemia. , 1985, Stroke.

[109]  J. Cramer,et al.  Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. , 1985, The New England journal of medicine.

[110]  G. Landi,et al.  Prognostic significance of hyperglycemia in acute stroke. , 1985, Archives of neurology.

[111]  T. Sundt,et al.  Emergency embolectomy for acute occlusion of the middle cerebral artery. , 1985, Journal of neurosurgery.

[112]  M. Winograd Heparin‐induced thrombocytopenia in patients with cerebrovascular ischemic disease , 1985, Neurology.

[113]  J. Lodder CT‐detected hemorrhagic infarction; relation with the size of the infarct, and the presence of midline shift , 1984, Acta neurologica Scandinavica.

[114]  M. Britton,et al.  Diagnostic errors discovered by CT in patients with suspected stroke , 1984, Neurology.

[115]  W. Hauser,et al.  Risks of seizure recurrence after an initial seizure , 1984 .

[116]  A. Nath,et al.  Immediate anticoagulation of embolic stroke: brain hemorrhage and management options. Cerebral Embolism Study Group. , 1984, Stroke.

[117]  M. Fisher,et al.  A Double Blind Trial of Naloxone in the Treatment of Acute Stroke , 1984, Stroke.

[118]  R. Cipolle,et al.  Heparin‐induced thrombocytopenia in patients with cerebrovascular ischemic disease , 1984, Neurology.

[119]  V. Moretti,et al.  DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF NALOXONE ON MOTOR DEFICITS IN ACUTE CEREBROVASCULAR DISEASE , 1984, The Lancet.

[120]  A. Ropper,et al.  Brain edema after stroke. Clinical syndrome and intracranial pressure. , 1984, Archives of neurology.

[121]  L. Wilkins Immediate anticoagulation of embolic stroke: a randomized trial. Cerebral Embolism Study Group. , 1983, Stroke.

[122]  R. Spetzler,et al.  High dose barbiturates in non-traumatic brain swelling. , 1983, Stroke.

[123]  H. Link,et al.  Evaluation of anticoagulants in patients with cerebral infarction with slight to moderate neurological deficit , 1983, Acta neurologica Scandinavica.

[124]  Daniel B Hier,et al.  Cerebral embolism in the Michael Reese Stroke Registry. , 1983, Stroke.

[125]  B. Dobkin Heparin for lacunar stroke in progression. , 1983, Stroke.

[126]  T. J. Iberti Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. , 1983, Neurosurgery.

[127]  F. Plum,et al.  Moderate hyperglycemia augments ischemic brain damage , 1982, Neurology.

[128]  A. Ropper,et al.  High dose barbiturates in non‐traumatic brain swelling: ICP reduction and effect on outcome. , 1982, Stroke.

[129]  D. W. Beck,et al.  Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. , 1982, Neurosurgery.

[130]  Richard L. Roller Recurrent embolic cerebral infarction and anticoagulation , 1982, Neurology.

[131]  M. Modic,et al.  Hemorrhage and anticoagulation after nonseptic embolic brain infarction , 1982, Neurology.

[132]  L Cocito,et al.  Epileptic seizures in cerebral arterial occlusive disease. , 1982, Stroke.

[133]  R. Koller Recurrent embolic cerebral infarction and anticoagulation. , 1982, Neurology.

[134]  D. Wiebers,et al.  Mechanisms and Timing of Deaths from Cerebral Infarction , 1981, Stroke.

[135]  F. Mcdowell,et al.  Treatment of progressing stroke. , 1980, Stroke.

[136]  U. de Faire,et al.  Hazards of therapy for excessive hypertension in acute stroke. , 2009, Acta medica Scandinavica.

[137]  H. Spinnler,et al.  Cerebellar softening , 1980, Annals of neurology.

[138]  G. Holmes The Electroencephalogram as a Predictor of Seizures following Cerebral Infarction , 1980, Clinical EEG.

[139]  J. Keane Retinal hemorrhages. Its significance in 100 patients with acute encephalopathy of unknown cause. , 1979, Archives of neurology.

[140]  G. Mulley,et al.  Dexamethasone in acute stroke. , 1978, British medical journal.

[141]  T. Sundt,et al.  Guidelines for the management of transient ischemic attacks. , 1978, Mayo Clinic proceedings.

[142]  H. L. Bleich,et al.  The Harvard Cooperative Stroke Registry , 1978, Neurology.

[143]  L. A. Rauscher,et al.  Mannitol dose requirements in brain-injured patients. , 1978, Journal of neurosurgery.

[144]  A. Wintzen,et al.  LOW-DOSE HEPARIN PROPHYLAXIS AGAINST DEEP-VEIN THROMBOSIS AFTER ACUTE STROKE , 1978, The Lancet.

[145]  M. L. Marsh,et al.  Neurosurgical Intensive Care , 1977, Anesthesiology.

[146]  H. Barnett,et al.  Cerebral Ischemia : The Role of Thrombosis and of Antithrombotic Therapy Study Group on Antithrombotic Therapy , 2005 .

[147]  R. Crowell STA-MCA bypass for acute focal cerebral ischemia , 1977 .

[148]  T. Langfitt,et al.  Treatment of intracranial hypertension. Analysis of 105 consecutive, continuous recordings of intracranial pressure. , 1977, Acta neurochirurgica.

[149]  J D Michenfelder,et al.  Sodium Nitroprusside: Pharmacology, Toxicology and Therapeutics , 1976, Anesthesiology.

[150]  C. Warlow,et al.  Deep venous thrombosis of the legs after strokes. Part I--incidence and predisposing factors. , 1976, British medical journal.

[151]  N. Marinovich,et al.  DOUBLE-BLIND TRIAL OF GLYCEROL THERAPY IN EARLY STROKE , 1976, The Lancet.

[152]  L. R. Caplan,et al.  Positional cerebral ischaemia. , 1976, Journal of neurology, neurosurgery, and psychiatry.

[153]  M. Raichle,et al.  A Pilot Study of Urokinase Therapy in Cerebral Infarction , 1976, Stroke.

[154]  J. Norris Steroid therapy in acute cerebral infarction. , 1976, Archives of neurology.

[155]  A L Smith,et al.  Barbiturate Protection in Acute Focal Cerebral Ischemia , 1974, Stroke.

[156]  H. Crockard,et al.  Evaluation of hyperventilation in treatment of head injuries. , 1974, British medical journal.

[157]  R. Bauer,et al.  Dexamethasone as Treatment in Cerebrovascular Disease. 2. A Controlled Study in Acute Cerebral Infarction , 1973, Stroke.

[158]  M. Brown,et al.  Mortality factors in patients with acute stroke. , 1973, JAMA.

[159]  J. Meyer,et al.  Double-blind evaluation of glycerol therapy in acute cerebral infarction. , 1972, Lancet.

[160]  L. Ng,et al.  Massive Cerebral Infarction with Severe Brain Swelling: A CLINICOPATHOLOGICAL STUDY , 1970, Stroke.

[161]  F. Mcdowell,et al.  Epileptic seizures in nonembolic cerebral infarction. , 1967, Archives of neurology.

[162]  F. Plum Brain swelling and edema in cerebral vascular disease. , 1966, Research publications - Association for Research in Nervous and Mental Disease.

[163]  J. F. Johnson,et al.  ANTICOAGULANTS PLUS STREPTOKINASE THERAPY IN PROGRESSIVE STROKE. , 1964, JAMA.

[164]  R. P. Mackay ANTICOAGULANT THERAPY IN CEREBROVASCULAR DISEASE. , 1964, JAMA.

[165]  J. F. Johnson,et al.  Therapeutic thrombolysis in cerebral thromboembolism , 1963, Neurology.

[166]  J. Toole,et al.  Anticoagulant therapy in cerebral infarction , 1962, Neurology.

[167]  Carter Ab Anticoagulant treatment in progressing stroke. , 1961 .

[168]  C. Fisher Anticoagulant therapy in cerebral thrombosis and cerebral embolism , 1961, Neurology.

[169]  C. Fisher The use of anticoagulants in cerebral thrombosis , 1958, Neurology.

[170]  M. Victor,et al.  Recurrent convulsive seizures as a sequel to cerebral infarction: a clinical and pathological study. , 1954, Brain : a journal of neurology.

[171]  S. Jasko,et al.  Therapy , 1881, The American journal of dental science.